259 related articles for article (PubMed ID: 15126355)
1. Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.
Stephen RL; Gustafsson MC; Jarvis M; Tatoud R; Marshall BR; Knight D; Ehrenborg E; Harris AL; Wolf CR; Palmer CN
Cancer Res; 2004 May; 64(9):3162-70. PubMed ID: 15126355
[TBL] [Abstract][Full Text] [Related]
2. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
3. A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.
Xu L; Han C; Wu T
J Biol Chem; 2006 Nov; 281(45):33982-96. PubMed ID: 16966336
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.
Cavaillès V; Gompel A; Portois MC; Thénot S; Mabon N; Vignon F
J Mol Endocrinol; 2002 Jun; 28(3):165-75. PubMed ID: 12063183
[TBL] [Abstract][Full Text] [Related]
7. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.
Mueller E; Smith M; Sarraf P; Kroll T; Aiyer A; Kaufman DS; Oh W; Demetri G; Figg WD; Zhou XP; Eng C; Spiegelman BM; Kantoff PW
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10990-5. PubMed ID: 10984506
[TBL] [Abstract][Full Text] [Related]
8. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
9. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 Breast Cancer Cells.
Nehdi A; Ali R; Alhallaj A; Alzahrani H; Samman N; Mashhour A; Baz O; Barhoumi T; Alghanem B; Khan A; Alriyees L; Boudjelal M
Molecules; 2019 May; 24(11):. PubMed ID: 31141879
[TBL] [Abstract][Full Text] [Related]
11. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
Qin C; Burghardt R; Smith R; Wormke M; Stewart J; Safe S
Cancer Res; 2003 Mar; 63(5):958-64. PubMed ID: 12615709
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between peroxisome proliferator-activated receptor delta and cytosolic phospholipase A(2)alpha/cyclooxygenase-2/prostaglandin E(2) signaling pathways in human hepatocellular carcinoma cells.
Xu L; Han C; Lim K; Wu T
Cancer Res; 2006 Dec; 66(24):11859-68. PubMed ID: 17178883
[TBL] [Abstract][Full Text] [Related]
14. A short and efficient synthesis of the pharmacological research tool GW501516 for the peroxisome proliferator-activated receptor delta.
Wei ZL; Kozikowski AP
J Org Chem; 2003 Nov; 68(23):9116-8. PubMed ID: 14604391
[TBL] [Abstract][Full Text] [Related]
15. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.
Sznaidman ML; Haffner CD; Maloney PR; Fivush A; Chao E; Goreham D; Sierra ML; LeGrumelec C; Xu HE; Montana VG; Lambert MH; Willson TM; Oliver WR; Sternbach DD
Bioorg Med Chem Lett; 2003 May; 13(9):1517-21. PubMed ID: 12699745
[TBL] [Abstract][Full Text] [Related]
16. PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress.
Ali F; Ali NS; Bauer A; Boyle JJ; Hamdulay SS; Haskard DO; Randi AM; Mason JC
Cardiovasc Res; 2010 Mar; 85(4):701-10. PubMed ID: 19903700
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
Gupta RA; Tan J; Krause WF; Geraci MW; Willson TM; Dey SK; DuBois RN
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13275-80. PubMed ID: 11087869
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
20. Ligand-activated PPARδ upregulates α-smooth muscle actin expression in human dermal fibroblasts: A potential role for PPARδ in wound healing.
Ham SA; Hwang JS; Yoo T; Lee WJ; Paek KS; Oh JW; Park CK; Kim JH; Do JT; Kim JH; Seo HG
J Dermatol Sci; 2015 Dec; 80(3):186-95. PubMed ID: 26481780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
